Get the Stockscreener App
1.81
4.62%
0.08
After Hours:
1.78
-0.03
-1.66%
Neuronetics Inc stock is traded at $1.81, with a volume of 807.96K.
It is up +4.62% in the last 24 hours and up +35.07% over the past month.
Neuronetics Inc a commercial-stage medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advance Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulation, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advance Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address the existing treatment options. The company operates in two segments: medical devices and clinic services.
See More
Previous Close:
$1.73
Open:
$1.78
24h Volume:
807.96K
Relative Volume:
0.37
Market Cap:
$125.95M
Revenue:
$151.64M
Net Income/Loss:
$-37.23M
P/E Ratio:
-3.3126
EPS:
-0.5464
Net Cash Flow:
$-13.58M
1W Performance:
-10.40%
1M Performance:
+35.07%
6M Performance:
-19.20%
1Y Performance:
-59.69%
1-Day Range:
$1.69
$1.84
1-Week Range:
$1.69
$2.025
52-Week Range:
$0.80
$4.8495
Neuronetics Inc Stock (STIM) Company Profile
Name
Neuronetics Inc
Sector
Industry
Phone
877-600-7555
Address
3222 PHOENIXVILLE PIKE, MALVERN, PA
Compare STIM vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
STIM
Neuronetics Inc
|
1.81 | 120.39M | 151.64M | -37.23M | -13.58M | -0.5464 |
ABT
Abbott Laboratories
|
104.49 | 179.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
336.74 | 126.60B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
84.22 | 106.51B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
45.51 | 65.77B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.04 | 47.58B | 6.30B | 1.07B | 1.09B | 1.8406 |
Neuronetics Inc Stock (STIM) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-13-24 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-13-21 | Downgrade | BTIG Research | Buy → Neutral |
| Oct-13-21 | Downgrade | William Blair | Outperform → Mkt Perform |
| Jan-22-21 | Upgrade | William Blair | Mkt Perform → Outperform |
| Feb-06-20 | Initiated | BTIG Research | Buy |
| Jul-24-18 | Initiated | Canaccord Genuity | Buy |
View All
Neuronetics Inc Stock (STIM) Latest News
Neuronetics Inc (STIM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Neuronetics Inc (STIM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Neuronetics, Inc. (STIM) stock price, news, quote and history - Yahoo Finance Australia
STIM|Neuronetics Inc|Price:1.730|Chg%:-0.150 - TradingKey
Neuronetics Inc (STIM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
Neuronetics, Inc. (STIM) Stock Price, News, Quote & History - Yahoo! Finance Canada
Neuronetics, Inc. Revenue Breakdown – NASDAQ:STIM - TradingView
What Does Jorey Chernett's Recent Buying Spree Signal for Neuronetics (STIM) - Kavout | AI
Neuronetics (STIM) grants 500,000 RSUs to EVP and CFO Naor Nir - Stock Titan
ETFs Investing in Neuronetics, Inc. Stocks - TradingView
Citizens reiterates Neuronetics stock rating on new CFO appointment By Investing.com - Investing.com Nigeria
Neuronetics names Nir Naor CFO - Medical Buyer
Citizens reiterates Neuronetics stock rating on new CFO appointment - Investing.com
Neuronetics appoints new CFO - MSN
symbol__ Stock Quote Price and Forecast - CNN
Neuronetics Appoints Naor as CFO - Moomoo
Press Release: Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes - Moomoo
Neuronetics names Nir Naor as CFO, promotes Anderson to EVP By Investing.com - Investing.com Nigeria
Neuronetics names Nir Naor as CFO, promotes Anderson to EVP - Investing.com
Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes - The Manila Times
Neuronetics appoints Nir Naor as EVP, CFO and Treasurer; W. Andrew Macan to depart - TradingView
Neuronetics, Inc. Announces Management Changes - marketscreener.com
Neuronetics: Nir Naor Appointed Chief Fincl Officer Effective July 23 >STIM - Moomoo
Greenbrook Gets New General Manager; Legal Head to Step Down Aug. 15 - Stock Titan
Neuronetics: A High-Stakes Turnaround Play with 143% Upside Potential - Kavout | AI
Why Is Neuronetics Stock Soaring Monday? - Benzinga
BTIG initiates Neuronetics stock with buy rating on mental health platform - Investing.com UK
STIM Initiated Coverage by BTIG -- Price Target Set at $5.00 - GuruFocus
BTIG initiates Neuronetics stock with buy rating on mental health platform By Investing.com - Investing.com South Africa
Neuronetics Price Target Announced at $5.00/Share by BTIG - Moomoo
Frontier tech research, news & data - MLQ.ai
Neuronetics Inc. STIM Slides As Weak Margins Pressure Stock - StocksToTrade
Neuronetics Inc. Stock Dips As Traders Weigh Losses And Cash Burn - timothysykes.com
Neuronetics: Top Line Growth, Low Valuation, But Gross Margin Struggles (NASDAQ:STIM) - Seeking Alpha
Neuronetics (STIM) Slips 8.6% as Bearish Pressure Intensifies – Key Support in FocusSchiff Line - dars.gov.et
Neuronetics Could Double, But The Balance Sheet May Crack First (NASDAQ:STIM) - Seeking Alpha
Q3 2025 Neuronetics Inc Earnings Call Transcript - GuruFocus
Neuronetics Inc. (STIM) Q1 2026 Earnings: EPS Beats Estimates, Shares Rise Despite Sparse Revenue DisclosureDiluted EPS Report - dars.gov.et
Form 4 Neuronetics Inc For: 15 July By Investing.com - Investing.com Nigeria
Neuronetics: Jorey Chernett acquires $62,300 common stock - Investing.com UK
Insider Buying: Jorey Chernett Acquires 35,000 Shares of Neurone - GuruFocus
Neuronetics: Jorey Chernett acquires $62,300 common stock By Investing.com - Investing.com South Africa
Neuronetics (NASDAQ: STIM) major holder buys 35,000 common shares - Stock Titan
Neuronetics (STIM) to Present at B. Riley Mind, Muscle & Vision Summit - Yahoo Finance
Neuronetics (STIM) EVP Cory Anderson reports PRSU awards tied to cash metrics - Stock Titan
Neuronetics Inc. (STIM) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Neuronetics to Participate in a Panel Discussion at B. Riley Securities Mind, Muscle and Vision Summit on July 16, 2026 - marketscreener.com
Neuronetics to Participate in a Panel Discussion at B. Riley Securities' Mind, Muscle & Vision Summit on July 16, 2026 - The Manila Times
Neuronetics to Participate at B. Riley Securities’ Mind, Muscle & Vision Summit - Quiver Quantitative
Neuronetics joins neuropsychiatry panel at B. Riley investor summit - Stock Titan
Neuronetics Inc Stock (STIM) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.79%
4.39%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):